<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3EA92C1-FCC2-4D8F-9546-7A9DAB980A9D"><gtr:id>E3EA92C1-FCC2-4D8F-9546-7A9DAB980A9D</gtr:id><gtr:name>University of Picardie Jules Verne</gtr:name><gtr:address><gtr:line1>33 rue Saint Leu</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/05A5A7E4-2E55-4D5B-80D7-E5B959133099"><gtr:id>05A5A7E4-2E55-4D5B-80D7-E5B959133099</gtr:id><gtr:name>Central Inst of Mental Health Mannheim</gtr:name><gtr:address><gtr:line1>Square J5</gtr:line1><gtr:line2>Suchtmedizin</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D66C0081-4798-4EC3-AC8A-28CFA84E34F2"><gtr:id>D66C0081-4798-4EC3-AC8A-28CFA84E34F2</gtr:id><gtr:name>University of Rouen</gtr:name><gtr:address><gtr:line1>Avenue de l'Universite</gtr:line1><gtr:line2>Technopole du Madrillet</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Brighton and Sussex Medical School</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3EA92C1-FCC2-4D8F-9546-7A9DAB980A9D"><gtr:id>E3EA92C1-FCC2-4D8F-9546-7A9DAB980A9D</gtr:id><gtr:name>University of Picardie Jules Verne</gtr:name><gtr:address><gtr:line1>33 rue Saint Leu</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/05A5A7E4-2E55-4D5B-80D7-E5B959133099"><gtr:id>05A5A7E4-2E55-4D5B-80D7-E5B959133099</gtr:id><gtr:name>Central Inst of Mental Health Mannheim</gtr:name><gtr:address><gtr:line1>Square J5</gtr:line1><gtr:line2>Suchtmedizin</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D66C0081-4798-4EC3-AC8A-28CFA84E34F2"><gtr:id>D66C0081-4798-4EC3-AC8A-28CFA84E34F2</gtr:id><gtr:name>University of Rouen</gtr:name><gtr:address><gtr:line1>Avenue de l'Universite</gtr:line1><gtr:line2>Technopole du Madrillet</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5BF4D79D-DFDF-44D8-9FBE-607A1C2B7891"><gtr:id>5BF4D79D-DFDF-44D8-9FBE-607A1C2B7891</gtr:id><gtr:firstName>Mary</gtr:firstName><gtr:otherNames>L</gtr:otherNames><gtr:surname>Phillips</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2DFB367E-B573-4DFE-99B9-0E2DA8CB5821"><gtr:id>2DFB367E-B573-4DFE-99B9-0E2DA8CB5821</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7561CBD8-8D97-4798-B555-3F2F4AC52FDC"><gtr:id>7561CBD8-8D97-4798-B555-3F2F4AC52FDC</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Norman</gtr:otherNames><gtr:surname>Stephens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4C02D2B4-F889-4121-8837-D9F9D5D290F1"><gtr:id>4C02D2B4-F889-4121-8837-D9F9D5D290F1</gtr:id><gtr:firstName>Theodora</gtr:firstName><gtr:surname>Duka</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/23870584-90CB-4ED9-A522-3735C753975E"><gtr:id>23870584-90CB-4ED9-A522-3735C753975E</gtr:id><gtr:firstName>Tamzin</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Ripley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400568"><gtr:id>5CB5AD5F-E752-437B-8202-E1A57C46D3DC</gtr:id><gtr:title>Sensitisation to alcohol withdrawal: consequences and mechanisms</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400568</gtr:grantReference><gtr:abstractText>Among those treated for alcoholism, a typical pattern consists of a period of problem drinking, treatment involving detoxification, a period of abstinence, which may be very short, followed by relapse. Such cycles are often repeated many times during an alcoholic career, each withdrawal episode increasing intensity of withdrawal and risk of seizures. Patterns of binge drinking by young adults, involving bouts of intoxication and withdrawal possess some features similar to repeated withdrawal. We have found that such individuals show impairments in cognitive and emotional competence, and we have been able to reproduce similar effects in rodents, in which we have begun to study the brain changes responsible for the deficits. The current project, to be undertaken by clinical and experimental scientists at the University of Sussex, and the Institute of Psychiatry, will extend this work to understand better the brain areas, and neuronal processes impaired by repeated withdrawal from alcohol. Using brain imaging and psychological testing of people who abuse alcohol, we will investigate whether repeated alcohol withdrawal, and binge drinking, compromise function of the frontal areas of the brain that are involved in judgement and control of behaviour, and which are likely to be important in controlling urges to drink, and of the brain area called the amygdala that is involved in emotions. Because it is difficult to discover whether differences observed between normal people and those who abuse alcohol are the cause of alcohol abuse, or its effect, related studies will be carried out in rats to determine whether repeated alcohol withdrawal causes related effects. Ultimately we would hope to be able to prevent brain changes that occur in withdrawal, and help alcoholics control their drinking more easily.</gtr:abstractText><gtr:technicalSummary>One of the major health concerns associated with alcoholism is brought about by repeated cycles of problem drinking, followed by detoxification, a period of abstinence, and finally relapse. Such cycles may be repeated many times during an alcoholic career, each successive withdrawal episode being associated with increased risk of seizures. We have shown that patients who have undergone repeated episodes of withdrawal also show altered affect, and deterioration of cognitive abilities when compared to patients with fewer withdrawals, and we have found related impairments in young binge drinkers. As well as being deleterious in their own right, such changes may also contribute to future drug taking behaviour, whilst related impairments in young binge drinkers may indicate a vulnerability to develop alcoholism. The proposed research will test our working hypothesis that many of the cognitive and emotional impairments observed following repeated experience of withdrawal are attributable to altered function of a system including prefrontal cortex and amygdala. In human alcoholics and binge drinkers neuropsychological tests sensitive to alterations in the brain areas concerned, combined with functional imaging, will be used to study changes in brain activation during the performance of these tasks. 
More detailed neuronal circuitry and underlying neurobiological mechanisms will be examined in parallel behavioural studies in rats and genetically manipulated mice. In animal studies the development and progression of withdrawal-kindling, following more severe withdrawal or a greater number of withdrawal cycles, will be studied using behavioural paradigms targeted at different brain regions postulated from imaging studies to be important in mediating the effects of repeated withdrawal. Chemical inactivation of these regions during withdrawal, followed by investigations of the subsequent effect on withdrawal-sensitive behavioural paradigms will then be used to study the functional importance of these regions during withdrawal. Finally, using pharmacological tools and transgenic mouse models, GABAergic and glutamatergic processes known to be involved in synaptic plasticity, and which seem likely to contribute to the synaptic sensitisation thought to underlie repeated withdrawal effects, will be studied. The ultimate aim of the project is to identify potential targets for drug treatments to prevent the consequences of repeated withdrawal in the alcoholic population.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>700000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>European Regional Development Fund (ERDF)</gtr:department><gtr:description>AlcoBinge</gtr:description><gtr:id>942DCD40-0239-404B-A2E3-1F70789A5551</gtr:id><gtr:impact>Multidisciplinary - molecular biology, behavioural neuroscience, brain imaging</gtr:impact><gtr:outcomeId>LCvHr7zzhUe-3</gtr:outcomeId><gtr:partnerContribution>Availability of techniques not available at Sussex.
Appointment of RA in Amiens to work on the project at SussexAvailability of techniques not available at Sussex</gtr:partnerContribution><gtr:piContribution>This is a cross-regional collaboration between the Universities of Sussex, Rouen and Amiens. The University of Sussex will study the consequences of binge drinking on impulsivity using a mouse model and human fMRI methods following on from the MRC grant</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Central Institute for Mental Health</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>central institute for mental health, mannheim</gtr:description><gtr:id>4122F0F2-C66D-4766-8FBF-0008308CFA50</gtr:id><gtr:impact>see publications, first author Loeber 19922568 19487491 19468716</gtr:impact><gtr:outcomeId>2BE4F2629B4-1</gtr:outcomeId><gtr:partnerContribution>Research collaboration. Partner contributed person and analysis expertise. See publications.</gtr:partnerContribution><gtr:piContribution>Hosted postdoctoral researcher and supervised her research</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Pfizer</gtr:description><gtr:id>9C53B23D-5476-4C47-A05B-26CEA5A7C59D</gtr:id><gtr:impact>method developed and transferred to Pfizer labs</gtr:impact><gtr:outcomeId>CB6CE05E536-1</gtr:outcomeId><gtr:partnerContribution>Hosting student during CASE award</gtr:partnerContribution><gtr:piContribution>development of methods for studying effects of chronic ethanol and potential drugs of abuse on rodent measures of impulsivity</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rouen</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Neurobiology</gtr:department><gtr:description>AlcoBinge</gtr:description><gtr:id>82BC5C76-3773-4815-8C24-637ED883F069</gtr:id><gtr:impact>Multidisciplinary - molecular biology, behavioural neuroscience, brain imaging</gtr:impact><gtr:outcomeId>LCvHr7zzhUe-2</gtr:outcomeId><gtr:partnerContribution>Availability of techniques not available at Sussex.
Appointment of RA in Amiens to work on the project at SussexAvailability of techniques not available at Sussex</gtr:partnerContribution><gtr:piContribution>This is a cross-regional collaboration between the Universities of Sussex, Rouen and Amiens. The University of Sussex will study the consequences of binge drinking on impulsivity using a mouse model and human fMRI methods following on from the MRC grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Psychiatry (GSK)</gtr:department><gtr:description>GSK</gtr:description><gtr:id>D8F61A2B-9F40-4AEC-853C-A70B75775D3C</gtr:id><gtr:impact>No outputs to date

Collaboration is in mouse behaviour</gtr:impact><gtr:outcomeId>ZDoXB1DSHEX-1</gtr:outcomeId><gtr:partnerContribution>Provsion of novel agent form testing utility as a treatment of alcohol abuse</gtr:partnerContribution><gtr:piContribution>Testing in mice of a novel agent for its potential utility in reducing alcohol intake</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Picardie Jules Verne (UPJV)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Neurobiology</gtr:department><gtr:description>AlcoBinge</gtr:description><gtr:id>A960D85B-F88B-4674-9B87-92BE76213363</gtr:id><gtr:impact>Multidisciplinary - molecular biology, behavioural neuroscience, brain imaging</gtr:impact><gtr:outcomeId>LCvHr7zzhUe-1</gtr:outcomeId><gtr:partnerContribution>Availability of techniques not available at Sussex.
Appointment of RA in Amiens to work on the project at SussexAvailability of techniques not available at Sussex</gtr:partnerContribution><gtr:piContribution>This is a cross-regional collaboration between the Universities of Sussex, Rouen and Amiens. The University of Sussex will study the consequences of binge drinking on impulsivity using a mouse model and human fMRI methods following on from the MRC grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC radio interview ds</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>92A8EA21-DC0B-42FE-96E7-3015D0FEA26B</gtr:id><gtr:impact>Participation in BBC Radio 4 broadcast on Chemistry of Addiction (over two weeks)

none</gtr:impact><gtr:outcomeId>866366FC1B6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society ds</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>78A154F2-A018-452A-B6D4-3C57E4DB804E</gtr:id><gtr:impact>Invited lecture to International meeting of Addiction workers. Audience consisted of addiction scientists, professionals, policy makers, and press

None</gtr:impact><gtr:outcomeId>E40778833C2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Television Horizon Prpgramme td</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>C4DEB086-2C33-443D-B7D4-BFDF21793F6D</gtr:id><gtr:impact>Participation in Horizon programme &amp;quot;Britain's most dangerous drug&amp;quot;. Presentation on effects of binge drinking on brain function

Further doscussion at Dana Centre. see http.www.danacentre.org.uk/events/2008/02/05/360</gtr:impact><gtr:outcomeId>8AA6EB64D1E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.danacentre.org.uk/events/2008/02/05/360</gtr:url><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Association Festival of Science td</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>9CC4859D-8CF6-490F-8496-34DF7DF029FB</gtr:id><gtr:impact>Presentation on alcohol, binge drinking and brain function

extensive press coverage</gtr:impact><gtr:outcomeId>BF713BEB3FE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship (Pfizer)</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>5695858B-8915-4433-8500-EC2821962051</gtr:id><gtr:outcomeId>9D3D20528F50</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>21000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AERC</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Alcohol Research UK</gtr:fundingOrg><gtr:id>028496B5-1A74-4234-8806-2678901D415E</gtr:id><gtr:outcomeId>Qbv4izwkBBh0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26700</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European Research Advisory Board (ERAB)</gtr:department><gtr:description>European Research Advisory Board (ERAB) Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>7F4C3A75-0449-4921-8F64-F512C7738D77</gtr:id><gtr:outcomeId>FB6C16C7A540</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>357435</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European Regional Development Fund (ERDF)</gtr:department><gtr:description>EU InterReg</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>02A0FEF7-DA06-409C-A3D8-BD0F049F9316</gtr:id><gtr:outcomeId>huD8XrDDFkN0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DFG, Travellining Fellowship for Dr Sabine Loeber</gtr:description><gtr:end>2009-06-02</gtr:end><gtr:fundingOrg>German Research Foundation (DFG)</gtr:fundingOrg><gtr:id>9C997A3D-0579-43CC-8849-D996E177EA35</gtr:id><gtr:outcomeId>5DEB28DC8900</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>74000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship (Johnson and Johnson)</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>5FAAC4B7-F63A-4F5A-BF43-831F2D26C43B</gtr:id><gtr:outcomeId>6C5D49A3AB40</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>D2C1A976-A91C-4C4D-9D94-C14298209447</gtr:id><gtr:outcomeId>P6dC47SXMm80</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESRC, PhD Studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Economic and Social Research Council</gtr:fundingOrg><gtr:id>693BC04B-FE03-440E-B167-7348D774889D</gtr:id><gtr:outcomeId>BB676C72C250</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>77D2F907-1D2C-4B1D-AE05-0C73A9E029DC</gtr:id><gtr:title>The influence of alcohol on basic motoric and cognitive disinhibition.</gtr:title><gtr:parentPublicationTitle>Alcohol and alcoholism (Oxford, Oxfordshire)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8768ac5910e5d4e17b565c718c3ec2e"><gtr:id>d8768ac5910e5d4e17b565c718c3ec2e</gtr:id><gtr:otherNames>Rose AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0735-0414</gtr:issn><gtr:outcomeId>1B6E172CB18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCF9140B-6198-4AB0-A5CD-D85405D3204B</gtr:id><gtr:title>Impaired fear recognition and attentional set-shifting is associated with brain structural changes in alcoholic patients.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6108ad6af8eda432bf19cf4418587145"><gtr:id>6108ad6af8eda432bf19cf4418587145</gtr:id><gtr:otherNames>Trick L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>doi_55f98398388e46a4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBC63AAD-D2D8-45F4-BF33-4018A2A02B74</gtr:id><gtr:title>Sp1 and NFkappaB pathways are regulated in brain in response to acute and chronic ethanol.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b65e5c2f5cfc13c162afd004ca52889"><gtr:id>9b65e5c2f5cfc13c162afd004ca52889</gtr:id><gtr:otherNames>Rulten SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>6464C4B6629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B50BD5D-1B02-43F0-8329-6D80B608A906</gtr:id><gtr:title>The effect of alcohol and repetition at encoding on implicit and explicit false memories.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3ad740d15b57797df74a97b7f8a4fb1"><gtr:id>d3ad740d15b57797df74a97b7f8a4fb1</gtr:id><gtr:otherNames>Garfinkel SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>92878021E97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5033534E-71BF-4848-832B-3722CB6F4E75</gtr:id><gtr:title>Prediction and uncertainty in human Pavlovian to instrumental transfer.</gtr:title><gtr:parentPublicationTitle>Journal of experimental psychology. Learning, memory, and cognition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6108ad6af8eda432bf19cf4418587145"><gtr:id>6108ad6af8eda432bf19cf4418587145</gtr:id><gtr:otherNames>Trick L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0278-7393</gtr:issn><gtr:outcomeId>pm_13472_22_21319920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEC0A3EE-2A3B-441E-B9A8-AF3DF2ED2AD0</gtr:id><gtr:title>Ethanol modifies the effect of handling stress on gene expression: problems in the analysis of two-way gene expression studies in mouse brain.</gtr:title><gtr:parentPublicationTitle>Brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b65e5c2f5cfc13c162afd004ca52889"><gtr:id>9b65e5c2f5cfc13c162afd004ca52889</gtr:id><gtr:otherNames>Rulten SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8993</gtr:issn><gtr:outcomeId>4B5399DD67D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1E27CE5-6262-43BE-882A-FABEC5E42313</gtr:id><gtr:title>Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5778e2c038c0477f0fed58629a850fa8"><gtr:id>5778e2c038c0477f0fed58629a850fa8</gtr:id><gtr:otherNames>Ripley TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>ay7vQBM7wNB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>683BA842-A28E-457A-BB49-5AAC3A26F915</gtr:id><gtr:title>Repeated withdrawal from ethanol spares contextual fear conditioning and spatial learning but impairs negative patterning and induces over-responding: evidence for effect on frontal cortical but not hippocampal function?</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bae40bf2bf390223a5ca2ddeac8919a"><gtr:id>8bae40bf2bf390223a5ca2ddeac8919a</gtr:id><gtr:otherNames>Borlikova GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>FE11F7EC9A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B1267D8-C970-44B9-BC0D-D7B468DC4CCB</gtr:id><gtr:title>Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18bfc7707aff90dd40d5eab68c9e6c0"><gtr:id>a18bfc7707aff90dd40d5eab68c9e6c0</gtr:id><gtr:otherNames>Leeman RF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>doi_13472_9_00192_x_</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF7BA9C0-7E51-4443-B827-8EA526BAD48A</gtr:id><gtr:title>The challenge of studying parallel behaviors in humans and animal models.</gtr:title><gtr:parentPublicationTitle>Current topics in behavioral neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9648c427cf7e119d5c5bc458f6e0ef"><gtr:id>cf9648c427cf7e119d5c5bc458f6e0ef</gtr:id><gtr:otherNames>Stephens DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1866-3370</gtr:issn><gtr:outcomeId>gXnaRbHw53E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5313FCE9-FC0E-4DC5-BA86-A657C18D5A2C</gtr:id><gtr:title>Extinction learning of stimulus reward contingencies: The acute effects of alcohol.</gtr:title><gtr:parentPublicationTitle>Drug and alcohol dependence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/686055edc649fdec9533ec849304171f"><gtr:id>686055edc649fdec9533ec849304171f</gtr:id><gtr:otherNames>Loeber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0376-8716</gtr:issn><gtr:outcomeId>AA6943B7C5D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44EAC9AD-3548-4DF8-BFFA-904408E73962</gtr:id><gtr:title>Previous experience of ethanol withdrawal increases withdrawal-induced c-fos expression in limbic areas, but not withdrawal-induced anxiety and prevents withdrawal-induced elevations in plasma corticosterone.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bae40bf2bf390223a5ca2ddeac8919a"><gtr:id>8bae40bf2bf390223a5ca2ddeac8919a</gtr:id><gtr:otherNames>Borlikova GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>EDA5703C50A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7ACC960-97C3-415C-9A61-054294E45900</gtr:id><gtr:title>Behavioural measures of frontal lobe function in a population of young social drinkers with binge drinking pattern.</gtr:title><gtr:parentPublicationTitle>Pharmacology, biochemistry, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef0d268d2a32e4de33689ad755e77bd0"><gtr:id>ef0d268d2a32e4de33689ad755e77bd0</gtr:id><gtr:otherNames>Scaife JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0091-3057</gtr:issn><gtr:outcomeId>22F1DB85B12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C7B538E-9806-40B0-9818-4965745014E2</gtr:id><gtr:title>Alcohol induces DNA damage and the Fanconi anemia D2 protein implicating FANCD2 in the DNA damage response pathways in brain.</gtr:title><gtr:parentPublicationTitle>Alcoholism, clinical and experimental research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b65e5c2f5cfc13c162afd004ca52889"><gtr:id>9b65e5c2f5cfc13c162afd004ca52889</gtr:id><gtr:otherNames>Rulten SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0145-6008</gtr:issn><gtr:outcomeId>E63C6DAEF1A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B3EEC9F-1671-4F89-9052-72672713FF63</gtr:id><gtr:title>Learning not to be impulsive: disruption by experience of alcohol withdrawal.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01089c1f04f0736b67ed02025c0bec23"><gtr:id>01089c1f04f0736b67ed02025c0bec23</gtr:id><gtr:otherNames>Walker SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>pm_13472_22_21509502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FF65F09-3FA8-4777-BBFF-C5D13A41E99B</gtr:id><gtr:title>Reward sensitivity: issues of measurement, and achieving consilience between human and animal phenotypes.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9648c427cf7e119d5c5bc458f6e0ef"><gtr:id>cf9648c427cf7e119d5c5bc458f6e0ef</gtr:id><gtr:otherNames>Stephens DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>sjJigpjEnVy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CA39E3B-D899-4601-B1A0-BA913C9B763F</gtr:id><gtr:title>Ethanol effects on impulsivity in two mouse strains: similarities to diazepam and ketamine.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac4f541d0b98a0d7a6cb011f3cb9523a"><gtr:id>ac4f541d0b98a0d7a6cb011f3cb9523a</gtr:id><gtr:otherNames>Oliver YP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>9F3B4A28C95</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FA02305-5774-4662-AAB3-754568DEC5B8</gtr:id><gtr:title>Measuring impulsivity in mice: the five-choice serial reaction time task.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c71d11dbecfbc87609cdb94361cae07"><gtr:id>8c71d11dbecfbc87609cdb94361cae07</gtr:id><gtr:otherNames>Sanchez-Roige S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>pm_13472_22_22089700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A35ABE8C-2F08-4D76-B37F-07884CAF9D61</gtr:id><gtr:title>Impairment of cognitive abilities and decision making after chronic use of alcohol: the impact of multiple detoxifications.</gtr:title><gtr:parentPublicationTitle>Alcohol and alcoholism (Oxford, Oxfordshire)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/686055edc649fdec9533ec849304171f"><gtr:id>686055edc649fdec9533ec849304171f</gtr:id><gtr:otherNames>Loeber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0735-0414</gtr:issn><gtr:outcomeId>390A931065D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CA15FA9-33F9-4BD5-B21B-EEE3585E99BD</gtr:id><gtr:title>Unique brain areas associated with abstinence control are damaged in multiply detoxified alcoholics.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb946697bc0f9579fb05719e815034d2"><gtr:id>bb946697bc0f9579fb05719e815034d2</gtr:id><gtr:otherNames>Duka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>ARLeKkLYLMv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FECF1A58-4DE9-44EE-81F7-0EFD72948CE7</gtr:id><gtr:title>Avoidance of alcohol-related stimuli in alcohol-dependent inpatients.</gtr:title><gtr:parentPublicationTitle>Alcoholism, clinical and experimental research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de6a5b4e5cdf81be864295d69bda291d"><gtr:id>de6a5b4e5cdf81be864295d69bda291d</gtr:id><gtr:otherNames>Townshend JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0145-6008</gtr:issn><gtr:outcomeId>515EFB20984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01ABF976-2B1F-4E27-A7A2-5054F8B922F5</gtr:id><gtr:title>Deficits in reward system activation and impulsivity: a predisposing condition to alcoholism?</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb946697bc0f9579fb05719e815034d2"><gtr:id>bb946697bc0f9579fb05719e815034d2</gtr:id><gtr:otherNames>Duka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_13472_22_21397741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C40AA41-DEF1-4BC7-8079-60C816F6A78C</gtr:id><gtr:title>Review. Cognitive and emotional consequences of binge drinking: role of amygdala and prefrontal cortex.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9648c427cf7e119d5c5bc458f6e0ef"><gtr:id>cf9648c427cf7e119d5c5bc458f6e0ef</gtr:id><gtr:otherNames>Stephens DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>4E757ED334A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B414D171-1D7F-4CE8-A1CA-C667063F0279</gtr:id><gtr:title>Effects of alcohol on inhibitory processes.</gtr:title><gtr:parentPublicationTitle>Behavioural pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8768ac5910e5d4e17b565c718c3ec2e"><gtr:id>d8768ac5910e5d4e17b565c718c3ec2e</gtr:id><gtr:otherNames>Rose AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0955-8810</gtr:issn><gtr:outcomeId>421B2149D58</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45231C66-BD69-41C4-9087-5734568D3A76</gtr:id><gtr:title>Experimental medicine in drug addiction: towards behavioral, cognitive and neurobiological biomarkers.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb946697bc0f9579fb05719e815034d2"><gtr:id>bb946697bc0f9579fb05719e815034d2</gtr:id><gtr:otherNames>Duka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>YJukAeRRYuM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B5BFFE7-F3C3-4A12-BCD5-A8D01A0A6535</gtr:id><gtr:title>Animal models/tests of drug addiction: a quest for the holy grail, or the pursuit of wild geese?</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9648c427cf7e119d5c5bc458f6e0ef"><gtr:id>cf9648c427cf7e119d5c5bc458f6e0ef</gtr:id><gtr:otherNames>Stephens DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>A7BFF35E317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A95A5E3-2F82-47C2-A209-F34278EE950A</gtr:id><gtr:title>Effects of repeated withdrawal from alcohol on recovery of cognitive impairment under abstinence and rate of relapse.</gtr:title><gtr:parentPublicationTitle>Alcohol and alcoholism (Oxford, Oxfordshire)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/686055edc649fdec9533ec849304171f"><gtr:id>686055edc649fdec9533ec849304171f</gtr:id><gtr:otherNames>Loeber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0735-0414</gtr:issn><gtr:outcomeId>UfAuSGu9xBq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDCA6AD5-BB66-4CFC-A028-774061889F35</gtr:id><gtr:title>Adolescent impulsivity phenotypes characterized by distinct brain networks.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f50b311db41106501f67c78a1eef397"><gtr:id>7f50b311db41106501f67c78a1eef397</gtr:id><gtr:otherNames>Whelan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_13472_22_22544311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5989F33-1033-4354-A830-ED8A2F06BFB9</gtr:id><gtr:title>Acute alcohol decreases performance of an instrumental response to avoid aversive consequences in social drinkers.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/686055edc649fdec9533ec849304171f"><gtr:id>686055edc649fdec9533ec849304171f</gtr:id><gtr:otherNames>Loeber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>B7FF991EA14</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F680A768-FD5A-4DAE-818B-0B3F5046647D</gtr:id><gtr:title>Withdrawal-associated increases and decreases in functional neural connectivity associated with altered emotional regulation in alcoholism.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab2bf1e133d120a13bda11edb26ed864"><gtr:id>ab2bf1e133d120a13bda11edb26ed864</gtr:id><gtr:otherNames>O'Daly OG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_13472_22_22617355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF7B4AD3-2B03-4396-9C78-EFC8B097AD7B</gtr:id><gtr:title>Acute alcohol impairs conditioning of a behavioural reward-seeking response and inhibitory control processes--implications for addictive disorders.</gtr:title><gtr:parentPublicationTitle>Addiction (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/686055edc649fdec9533ec849304171f"><gtr:id>686055edc649fdec9533ec849304171f</gtr:id><gtr:otherNames>Loeber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0965-2140</gtr:issn><gtr:outcomeId>4F3BE079E99</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400568</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>